Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

The medication lopinavir-ritonavir may cause severe hair loss.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Six African American women experienced hair loss after switching to a new HIV medication.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Hair loss doesn't affect COVID-19 severity.

Tisseel shows promise for bone graft stabilization but needs more clinical trials to confirm its effectiveness.

Combination therapy with QR 678 Neo and 5% Minoxidil is most effective for male hair loss.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Iron nanoparticles made from pumpkin extract effectively treated burns and promoted healing in mice.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

PSA could be a marker for hyperandrogenism in women, but more research is needed.